AbSolute ® High Cap High Capacity Protein A Media BioSC ® Sequential MultiColumn Chromatography Integrated Continuous Biomanufacturing, 21th October 2013.

Slides:



Advertisements
Similar presentations
Bringing the Powerful Application of Outsourced Manufacturing… …to the Solar Industry.
Advertisements

End-to-end continuous production of complex recombinant proteins Integration of perfusion cultivation and automated multi-step purification
Outline Introduction DSM Biologics DSM XD® Technology
UPSTREAM DEVELOPMENT OF HIGH CELL DENSITY, PERFUSION PROCESSES FOR CONTINUOUS MANUFACTURING Tim Johnson, Ph.D. October 21, 2013.
Solid Power ® XL PRESENTER NAME PRESENTER TITLE DD MONTH YYYY.
1. 2 Flotation Matrix 100™ Driving Measurable Quality & Performance Improvements.
UCL Decisional Tools Research
The amazing ability of continuous chromatography to adapt to a moving environment. Roger-Marc Nicoud, Founder of Novasep Barcelona, October 2013.
Johnson Controls1 YORK Model YVAA Air-Cooled Chillers Variable Speed Screw, tons.
The Biopharmaceutical Industry is Changing
ION EXCHANGE CHROMATOGRAPHY PREPARED BY- MD.MARUF HASSAN.
It Pays to be Smart Efficiency Flexibility Reliability Savings
Process Selection.
Bio-manufacturing Overview
IEX Chromatography Presented by: Nikki Apostolakis Helen So Tiffany Yu CHEE450: Engineering Biology.
Industrially Scaleable Process for the Purification and Refolding of Inclusion Body Recombinant Protein BELINDA C. CLARKE 1, GARETH M. FORDE 1, CHARLES.
MANAGING DEMAND AND CAPACITY Donna J. Hill, Ph.D. Fall 2000.
Metal Chelate Affinity Chromatography Wenbo Dong Yagmur Yagdiran.
Batch Processing Optimal Design and Scheduling
Novasep Process: TangenX Tangential Flow Filtration Products
Introduction Opportunity Market potential of recombinant drugs Problem Lack of manufacturing capacity Solution PharmOut: Contract BioManufacturing.
Platform downstream processes in the age of continuous chromatography: A case study Mark Brower BioProcess Technology & Expression Bioprocess Development.
High-throughput screening of HIC media in PreDictor™ plates for capturing a recombinant protein from E.coli Charlotte Brink, Carina Engstrand, Eva Heldin.
Continuous Antibody Capture with Protein A Countercurrent Tangential Chromatography: A New Column-Free Approach for Antibody Purification Andrew.
Chapter 4 Process Design.
Interference Cancellation as a Mobile Enhancement to Improve Spectral Efficiency IEEE ComSoc Denver Chapter January 16, 2007.
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous.
Cold ethanol precipitation and calcium-phosphate flocculation of recombinant antibodies University of Natural Resources and Life Sciences Vienna, Austria.
Facility Drivers for Housing Start-to-Finish Continuous Bioprocessing. Disruptive changes in scale & operational expectations vs. traditional batch operations.
Simulation Of Bioprocess ERT Modeling and Assessment in Process Development.
Impact of Technology on Merchandising Course Project Ben Fudge Fashion Merchandising Planning and Control I.
AFFINITY CHROMATOGRAPHY Presented By: Salma Al-Salman
CHROMATOGRAPHY. A process to separate molecules to purify them.
Sizing Variable Flow Piping – An Opportunity for Reducing Energy
Evaluation of Viral Clearance Studies Mahmood Farshid, Ph.D. Div. Of Hematology OBRR/ CBER/FDA.
Research Advances Towards Low Cost, High Efficiency PEM Electrolysis Dr. Katherine Ayers Presented by: Larry Moulthrop NHA 2010, Long Beach, CA.
Tritium Fuel Cycle System Modeling with ASPEN -ISS and FCU
Nguyen Thi Kim Phuong Institute of Chemical Technology
1 Views expressed in this presentation are my own, and do not necessarily reflect official FDA opinions/policy Views expressed in this presentation are.
Protein Purification by Ion Exchange Chromatography
Protein Purification for Crystallization Dr Muhammad Imran Forman Christian College (A Chartered University) Dr Muhammad Imran Forman Christian College.
Tackling I/O Issues 1 David Race 16 March 2010.
1 Mix Model for Executives FMS 200 Series FBP-FMS288A.
Taking your Business Technology Further. First Communications: At A Glance Technology Provider since 1998, serving thousands of Businesses throughout.
Industrial Manufacturing of Plasmid DNA 학부 4 금현우 학부 3 강유리.
New Light Path TM Services. slide 2 Light Path TM : streamlined custom material supply for discovery to early development n Leverage Lonza’s proven technology.
In the name of God. Common Technical Document On Biotech.
Product Overview Features and Benefits How it works Availability Success Stories Villeroy and Boch Feed Energy Saint Gobain Energy Saving Process Site.
Extreme Scale Infrastructure
Bioreactor Harvest miniBIOMAN 2017
Purification Of Proteins.
Purification of Green Fluorescent Protein
Chapter 11 -Downstream Processing
Ioannis Markidis WISE CDT PhD Student, University of Bath
Benefits of UV-LED Technology
Downstream Processing
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Data Center Cooling Market.
Water Quality Water Quality Testimonials:
Geoff Bell - Microbiogen
Building Competitive advantage through functional level strategies
Affinity Chromatography
Building Competitive advantage through functional level strategies
The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing  Adam C. Fisher, Mark-Henry Kamga,
The CaptureSMB process principle
Sustainable Industrial waste water management
Purification of Green Fluorescent Protein
AICHE Contest Week 3 Last Lecture
1. Downstream Processing: Purification
David Thornton1, Xiqin Yang1, Gary Yanik2 and Leo Hsu1*
Presentation transcript:

AbSolute ® High Cap High Capacity Protein A Media BioSC ® Sequential MultiColumn Chromatography Integrated Continuous Biomanufacturing, 21th October 2013 Rousset Fabien Ph.D. Head of Biopharma technologies

Novasep’s proven expertise  Pioneer in 1990’s of separation of optical isomers  Since 1990, Novasep has developed simulation software and proprietary chromatography technologies (Varicol®…)  Numerous APIs were purified using continuous chromatography technologies  3 Novasep sites are using FDA-inspected SMB systems  …and 15 APIs are produced at commercial scale (Pfizer, UCB, Cephalon, Lundbeck…)  Novasep centers of expertise for continuous chromatography: US (Boothwin), EU (Pompey, Pompey & Chasse sur Rhône) and Asia (Shanghai)  Novasep are now applying this proven expertise in cGMP continuous chromatography to the BioPharma industry, bringing dramatic cost reductions and process efficiency.

Will it worth a trial?

How far a Sequential Multi-Column Chromatography (SMCC) process from a batch process is? SMCC with BioSC®

Load (mg/ml bed) Breakthrough (C/Co) Loading Leaking Stop Batch chromatography Batch Chromatography Resin is NOT used at its maximum capacity Wash Elution Reg/Eq.

 With increasing velocities, leaking occurs sooner Breakthrough (C/Co) Load SMCC with BioSC®

100%66% 99%37% 80%30%04% 83% Single 100cm/h 68% Single 200cm/h 38% Single 400cm/h SMCC with 2 columns SMCC with 3 columns

Sub-Column 1 Sub-Column 2 Sub-Column 3 Sub-Column 4 Wash Elution Reg/Eq. Loading Start of production 1 st cycle Resin IS used at its maximum capacity Target molecule is NOT lost SMCC with BioSC® 8

Compromise to be found: Thermodynamics “DBC” vs Kinetics “Flow Rate” SMCC/BioSC® Affinity Chromatography Batch Affinity Chromatography Kinetics is not a limitation anymore: “SBC” & high Flow Rate for max of productivity SMCC with BioSC® 9

DBC SBC Resin (L) Time Prod. (hr) Productivity (gr/L/day) Buffer cons. (L/gr) SMCC Batch

SMCC with BioSC® Load Eq. Wash* Eq. Load Wash Patent EP Seq.1 Seq.2 Seq.3 Load Wash Seq.4 SMCC on 2 to 6 columns: Minimize the loss during wash Optimize sequence vs FR & wash Discontinuity enables max productivity …

Sub-Column 1 Sub-Column 2 Sub-Column 3 Sub-Column 4 Start of production 1 st cycle Steady State SMCC with BioSC® 12 pH Cond UV… In Process Monitoring: Patent US 8,216,475 (Adv. Control Syst.)

SMCC with BioSC®(On Line Monitoring) Wash1 Wash2ElutionReg.Equi.LoadingWash*1 col.2 Wash*2 col.2 Loading Wash*1 col.3 Wash*2 col.3Wash*1 col.4 Wash*2 col.4 Loading

SMCC with BioSC® (On Line Monitoring)  From cycle to cycle and from column to column, the BioSC® shows excellent robustness

Sub-Column 1 Sub-Column 2 Sub-Column 3 Sub-Column 4 Start of production 1 st cycle Steady State End of production last cycle SMCC using BioSC® 15 Pre-loading, conditionning, Cleaning in place, steady state and end of production are sequences that can be put in series

SMCC using BioSC® How to define a SMCC sequence?

Applications Time to market Resin consumption Productivity Buffer consumption What are your constraints? What is your objective? Other constraints Footprint OPEX CQAs

 Affinity, IEX, HIC, by maximing resin utilization  mAbs, blood proteins, vaccines by protecting target molecules  Perfusion, Fed-batch/ batch by streamlining all processes Valuable technology for… SMCC using BioSC® 18

 Optimize COGs (resin and buffers) and Labor time  Reduce footprint (for multi-products facility…)  with no change of process parameters (Branded and Biogenerics/Biosimilars)  Optimal solution for low titers / large volumes Unique solution when OPEX/CAPEX must be driven down SMCC using BioSC® 19

 Number of simultaneous steps can be greater than 3  Can operate with only 2 columns  Enables to rehabilitate old slow processes requesting more than 4 columns  Enabled by dedicated simulation/optimization software BioSC® helps to optimize processes as SMCC using BioSC® 20

SMCC using BioSC® 21 Dedicated Optimisation/Simulation Software for BioSC®: ColHelp®

Major testimonials  Amgen, IBC Seattle March 2011  Seatlle Genetics, BPI Providence Oct.2012  Bayer Technology Services, BPI Boston Sept.2013  In all studies, HCP clearance, purity, yield, DNA removal, proA leaching remains similar comparing SMCC to batch process  Some questions remain to be addressed as process validation, viral clearance, resin lifetime.

SMCC with BioSC®

BioSC® Product line Production Lab scale Modularity is offered for the design of your BioSC®

“If I have seen further it is by standing on the shoulders of giants” Isaac NEWTON.

Thank you for your attention!

Productivity Productivity Comparison (Steady State) 4 11 BioSC® Case Study 2

The current SMCC productivity numbers (g/Lr/day and g/Lr) are for steady-state mode Start-up and end of production sequences decrease productivity due to lower loading during initial loop and elution of all columns during final loop Delivers significant economy of scale ~5-6 Fold increase in productivity ~1.3-2 Fold reduction in water usage Positively impacts facility CapEx, foot print, utilities, tanks, etc. Increase in process speed BioSC® Case Study 2

BioSC® Case Study 3 ( 0.2 g mAb /L ) Run # mAb load (g/L) V(load) cm/h V(other) cm/h Yield cm/h Purity (SEC) % HCP ppm/IgG Protein-A ppm/IgG BioSC can easily adsorb process variations without CQAs and process efficiency impacts - The full utilization of the resin does not lead to process characteristics decrease